Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis

被引:313
作者
Cai, Jie [1 ]
Chen, Hongda [2 ]
Lu, Ming [2 ]
Zhang, Yuhan [2 ]
Lu, Bin [2 ]
You, Lei [1 ]
Zhang, Taiping [1 ]
Dai, Min [2 ]
Zhao, Yupei [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Gen Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Off Canc Screening, Natl Canc Ctr,Natl Clin Res Ctr Canc,Canc Hosp, Beijing 100021, Peoples R China
关键词
Pancreatic cancer; Trend; Screening; Prediction model; Biomarker; MUCINOUS CYSTIC NEOPLASMS; GENOME-WIDE ASSOCIATION; OVARIAN-TYPE STROMA; POOLED ANALYSIS; CLINICOPATHOLOGICAL CHARACTERISTICS; COFFEE CONSUMPTION; CLINICAL-FEATURES; CIGARETTE-SMOKING; SOFT DRINK; VITAMIN-D;
D O I
10.1016/j.canlet.2021.06.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic cancer is a malignancy with poor prognosis and high mortality. The recent increase in pancreatic cancer incidence and mortality has resulted in an increased number of studies on its epidemiology. This comprehensive and systematic literature review summarizes the advances in the epidemiology of pancreatic cancer, including its epidemiological trends, risk factors, risk prediction models, screening modalities, and prognosis. The risk factors for pancreatic cancers can be categorized as those related to individual characteristics, lifestyle and environment, and disease status. Several prediction models for pancreatic cancer have been developed in populations with new-onset diabetes or a family history of pancreatic cancer; however, these models require further validation. Despite recent progress in pancreatic cancer screening, the quantity and quality of related studies are also unsatisfactory, especially with respect to the identification of high-risk populations and development of effective screening modality. Apart from the populations with familial genetic risk and those at a high risk of sporadic pancreatic cancer, risk factors such as new-onset diabetes may be a new direction for timely intervention. We hope this work will provide new ideas for further prevention and treatment of pancreatic cancer.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 143 条
[11]   Development of a high risk pancreatic screening clinic using 3.0 T MRI [J].
Barnes, Chad A. ;
Krzywda, Elizabeth ;
Lahiff, Shannon ;
McDowell, Dena ;
Christians, Kathleen K. ;
Knechtges, Paul ;
Tolat, Parag ;
Hohenwalter, Mark ;
Dua, Kulwinder ;
Khan, Abdul H. ;
Evans, Douglas B. ;
Geurts, Jennifer ;
Tsai, Susan .
FAMILIAL CANCER, 2018, 17 (01) :101-111
[12]   Physical activity and risk of pancreatic cancer: a systematic review and meta-analysis [J].
Behrens, Gundula ;
Jochem, Carmen ;
Schmid, Daniela ;
Keimling, Marlen ;
Ricci, Cristian ;
Leitzmann, Michael F. .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2015, 30 (04) :279-298
[13]   Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies [J].
Ben, Qiwen ;
Xu, Maojin ;
Ning, Xiaoyan ;
Liu, Jun ;
Hong, Shangyou ;
Huang, Wen ;
Zhang, Huagao ;
Li, Zhaoshen .
EUROPEAN JOURNAL OF CANCER, 2011, 47 (13) :1928-1937
[14]   Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019 [J].
Bosetti, C. ;
Santucci, C. ;
Gallus, S. ;
Martinetti, M. ;
La Vecchia, C. .
ANNALS OF ONCOLOGY, 2020, 31 (05) :558-568
[15]   A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes [J].
Boursi, Ben ;
Finkelman, Brian ;
Giantonio, Bruce J. ;
Haynes, Kevin ;
Rustgi, Anil K. ;
Rhim, Andrew D. ;
Mamtani, Ronac ;
Yang, Yu-Xiao .
GASTROENTEROLOGY, 2017, 152 (04) :840-+
[16]   Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer [J].
Buscail, Louis ;
Bournet, Barbara ;
Cordelier, Pierre .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2020, 17 (03) :153-168
[17]   Screening for early pancreatic neoplasia in high-risk individuals: A prospective controlled study [J].
Canto, Marcia Irene ;
Goggins, Michael ;
Hruban, Ralph H. ;
Petersen, Gloria M. ;
Giardiello, Francis M. ;
Yeo, Charles ;
Fishman, Elliott K. ;
Brune, Kieran ;
Axilbund, Jennifer ;
Griffin, Constance ;
Ali, Syed ;
Richman, Jeffrey ;
Jagannath, Sanjay ;
Kantsevoy, Sergey V. ;
Kalloo, Anthony N. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (06) :766-781
[18]   International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer [J].
Canto, Marcia Irene ;
Harinck, Femme ;
Hruban, Ralph H. ;
Offerhaus, George Johan ;
Poley, Jan-Werner ;
Kamel, Ihab ;
Nio, Yung ;
Schulick, Richard S. ;
Bassi, Claudio ;
Kluijt, Irma ;
Levy, Michael J. ;
Chak, Amitabh ;
Fockens, Paul ;
Goggins, Michael ;
Bruno, Marco .
GUT, 2013, 62 (03) :339-347
[19]   Frequent Detection of Pancreatic Lesions in Asymptomatic High-Risk Individuals [J].
Canto, Marcia Irene ;
Hruban, Ralph H. ;
Fishman, Elliot K. ;
Kamel, Ihab R. ;
Schulick, Richard ;
Zhang, Zhe ;
Topazian, Mark ;
Takahashi, Naoki ;
Fletcher, Joel ;
Petersen, Gloria ;
Klein, Alison P. ;
Axilbund, Jennifer ;
Griffin, Constance ;
Syngal, Sapna ;
Saltzman, John R. ;
Mortele, Koenraad J. ;
Lee, Jeffrey ;
Tamm, Eric ;
Vikram, Raghunandan ;
Bhosale, Priya ;
Margolis, Daniel ;
Farrell, James ;
Goggins, Michael .
GASTROENTEROLOGY, 2012, 142 (04) :796-804
[20]   Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance [J].
Cascetta, Priscilla ;
Cavaliere, Alessandro ;
Piro, Geny ;
Torroni, Lorena ;
Santoro, Raffaela ;
Tortora, Giampaolo ;
Melisi, Davide ;
Carbone, Carmine .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)